{
    "organizations": [],
    "uuid": "3156c23941150c01800c65112651a307184980ce",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-audentes-therapeutics-reports-qtrl/brief-audentes-therapeutics-reports-qtrly-loss-per-share-0-74-idUSASC0A12I",
    "ord_in_thread": 0,
    "title": "BRIEF-Audentes Therapeutics Reports Qtrly Loss Per Share $0.74",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - Audentes Therapeutics Inc:\n* AUDENTES THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE\n* AUDENTES THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.74\n* AUDENTES THERAPEUTICS INC - AT MARCH 31, 2018, AUDENTES HAD CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS OF $326.1 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-10T04:12:00.000+03:00",
    "crawled": "2018-05-10T17:35:55.036+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "audentes",
        "therapeutic",
        "inc",
        "audentes",
        "therapeutic",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "provides",
        "corporate",
        "update",
        "audentes",
        "therapeutic",
        "inc",
        "qtrly",
        "loss",
        "per",
        "share",
        "audentes",
        "therapeutic",
        "inc",
        "march",
        "audentes",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}